Imricor Medical Systems, Inc. (ASX:IMR)
Australia · Delayed Price · Currency is AUD 1.880
+0.030 (1.62%)
Jan 16, 2026, 4:10 PM AEST
Imricor Medical Systems Market Cap
Imricor Medical Systems has a market cap or net worth of 603.38 million as of January 16, 2026. Its market cap has increased by 71.13% in one year.
Market Cap
603.38M
Enterprise Value
564.43M
Revenue
1.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.88
Market Cap Chart
Since August 30, 2019, Imricor Medical Systems's market cap has increased from 87.01M to 603.38M, an increase of 593.46%. That is a compound annual growth rate of 35.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 592.15M | 20.59% |
| Dec 31, 2025 | 491.05M | 33.64% |
| Dec 31, 2024 | 367.44M | 281.62% |
| Dec 29, 2023 | 96.28M | 74.29% |
| Dec 30, 2022 | 55.24M | -61.62% |
| Dec 31, 2021 | 143.95M | -49.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 83.55B |
| Pro Medicus | 21.90B |
| Cochlear | 17.28B |
| Sonic Healthcare | 11.38B |
| Ramsay Health Care | 8.25B |
| Ansell | 4.82B |
| Telix Pharmaceuticals | 3.73B |
| Mesoblast | 3.50B |